Cytosorbents Cor (CTSO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -5,129 | -8,198 | -2,701 | 469 | -1,479 |
| Depreciation Amortization | 667 | 2,451 | 1,817 | 1,226 | 595 |
| Accounts receivable | 310 | 423 | 560 | 257 | -80 |
| Other Working Capital | 1,255 | -1,030 | 135 | 869 | -396 |
| Other Operating Activity | 1,735 | -6,023 | -7,363 | -7,796 | -2,106 |
| Operating Cash Flow | $-1,162 | $-12,377 | $-7,552 | $-4,975 | $-3,466 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | 15 | -88 | -56 | -39 | -2 |
| Purchase Sale Intangibles | -61 | -327 | -68 | -140 | -45 |
| Other Investing Activity | -61 | -327 | -68 | -140 | -45 |
| Investing Cash Flow | $-46 | $-415 | $-124 | $-179 | $-47 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 2,478 | 0 | 0 | N/A |
| Common Stock Issued | N/A | 6,831 | 1,439 | 6,831 | 6,831 |
| Other Financing Activity | 0 | 0 | 5,392 | 0 | 0 |
| Financing Cash Flow | $0 | $9,309 | $6,831 | $6,831 | $6,831 |
| Exchange Rate Effect | -228 | 1,490 | 139 | 285 | 28 |
| Beginning Cash Position | 7,771 | 9,764 | 9,764 | 9,764 | 9,764 |
| End Cash Position | 6,335 | 7,771 | 9,058 | 11,726 | 13,110 |
| Net Cash Flow | $-1,436 | $-1,993 | $-706 | $1,962 | $3,346 |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,162 | -12,377 | -7,552 | -4,975 | -3,466 |
| Capital Expenditure | -11 | -164 | -56 | -39 | -2 |
| Free Cash Flow | -1,173 | -12,541 | -7,608 | -5,014 | -3,468 |